HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?

Abstract
Polymyositis and dermatomyositis are inflammatory muscular diseases of unknown etiology which have interstitial pneumonitis as a serious complication. From 1987 to 1994, we used cyclosporine to treat 14 polymyositis/dermatomyositis patients (8 with and 6 without interstitial pneumonitis). In combination with prednisolone, cyclosporine was either added to or substituted for conventional cytotoxic drugs (azathioprine, cyclophosphamide and methotrexate). Cyclosporine was effective against both myositis and interstitial pneumonitis when used early in the course of the disease.
AuthorsK Maeda, R Kimura, K Komuta, T Igarashi
JournalScandinavian journal of rheumatology (Scand J Rheumatol) Vol. 26 Issue 1 Pg. 24-9 ( 1997) ISSN: 0300-9742 [Print] England
PMID9057798 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Cyclosporine
Topics
  • Adult
  • Cyclosporine (therapeutic use)
  • Dermatomyositis (complications, drug therapy)
  • Female
  • Humans
  • Lung Diseases, Interstitial (drug therapy, etiology)
  • Male
  • Middle Aged
  • Polymyositis (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: